In addition, use of the LURIC cohort, which was recruited on the basis of high CAD risk and included outcomes from coronary angiograms, enabled well‐powered analysis of the relationship between sclerostin and detailed measures of CAD. This evidence concerns the gene SOST and coronary artery disorder.